General Information
Version
8.2
Revision date
2024-05-17
Product name
Chlorfenvinphos
CAS No.
470-90-6
1.2.1 Relevant identified uses
Laboratory chemicals, Synthesis of substances
Emergency telephone
+1-703-527-3887
Icons in SDS
Company Information
company name
MilliporeSigma Canada Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H300, H311, H400, H410
Hazard statements
Code
Statements
H300
Fatal if swallowed
Section 2
SECTION 2: Hazards identification
GHS Classification Classification of the substance or mixture GHS Classification in accordance with Hazardous Products Regulations (HPR) (SOR/2015-17) Acute toxicity, Oral (Category 2), H300 Acute toxicity, Dermal (Category 3), H311 Short-term (acute) aquatic hazard (Category 1), H400 Long-term (chronic) aquatic hazard (Category 1), H410 For the full text of the H-Statements mentioned in this Section, see Section 16
Signal word
Danger
Hazard statements
H300 Fatal if swallowed. H311 Toxic in contact with skin. H410 Very toxic to aquatic life with long lasting effects.
Precautionary statements
P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing. P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/ doctor if you feel unwell. P361 + P364 Take off immediately all contaminated clothing and wash it before reuse. P391 Collect spillage. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
- none
2.1 Classification of the substance or mixture
GHS Classification in accordance with Hazardous Products Regulations (HPR) (SOR/2015-17) Acute toxicity, Oral (Category 2), H300 Acute toxicity, Dermal (Category 3), H311 Short-term (acute) aquatic hazard (Category 1), H400 Long-term (chronic) aquatic hazard (Category 1), H410 For the full text of the H-Statements mentioned in this Section, see Section 16.